NEM
38
4
ORLY
60
2
RIG
28
2
GD
63
4
CCL
46
3
MKC
33
-2
HCP
60
-2
BF.B
48
-3
SWKS
59
-3
NTRS
39
2
WFC
61
3
NSC
50
2
WBA
34
7
L
71
3
LYB
32
3
AN
50
-2
OKE
62
6
BXP
46
2
MCHP
55
4
EXPD
53
2
NEM
38
4
ORLY
60
2
RIG
28
2
GD
63
4
CCL
46
3
MKC
33
-2
HCP
60
-2
BF.B
48
-3
SWKS
59
-3
NTRS
39
2
WFC
61
3
NSC
50
2
WBA
34
7
L
71
3
LYB
32
3
AN
50
-2
OKE
62
6
BXP
46
2
MCHP
55
4
EXPD
53
2
Financhill
Back

VICI Properties Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
38

VICI
VICI Properties

Last Price:
28.11
Seasonality Move:
3.34%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Sell
38
VICI Properties (VICI) is a Sell

Is VICI Properties a Buy, Sell or Hold?

  • The current VICI Properties [VICI] share price is $28.11. The Score for VICI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • VICI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VICI Stock Price Chart

What is VICI Properties's stock price today?

  • The VICI Properties share price today is $28.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VICI is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

VICI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: -98109 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.99 - 29.69) Sell
Bollinger Bands (100): (28.33 - 29.89) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

VICI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.24 Sell
20-day SMA: 28.48 Sell
50-day SMA: 28.7 Sell
200-day SMA: 29.52 Sell
8-day EMA: 28.27 Sell
20-day EMA: 28.5 Sell
50-day EMA: 28.79 Sell
200-day EMA: 29.63 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

VICI Properties Earnings Growth & VICI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.02 per share, an increase this year of $0.12 per share, and an increase next year of $0.10 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

VICI Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):